These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 10803523)
1. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A. Møller MB; Kania PW; Ino Y; Gerdes AM; Nielsen O; Louis DN; Skjødt K; Pedersen NT Leukemia; 2000 May; 14(5):898-904. PubMed ID: 10803523 [TBL] [Abstract][Full Text] [Related]
2. Molecular control of the cell cycle in cancer: biological and clinical aspects. Møller MB Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137 [TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology]. Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576 [TBL] [Abstract][Full Text] [Related]
4. Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma. Møller MB; Ino Y; Gerdes AM; Skjødt K; Louis DN; Pedersen NT Leukemia; 1999 Mar; 13(3):453-9. PubMed ID: 10086736 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069 [TBL] [Abstract][Full Text] [Related]
7. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Chiarle R; Budel LM; Skolnik J; Frizzera G; Chilosi M; Corato A; Pizzolo G; Magidson J; Montagnoli A; Pagano M; Maes B; De Wolf-Peeters C; Inghirami G Blood; 2000 Jan; 95(2):619-26. PubMed ID: 10627471 [TBL] [Abstract][Full Text] [Related]
8. Rb and E2F-1 regulate telomerase activity in human cancer cells. Crowe DL; Nguyen DC Biochim Biophys Acta; 2001 Mar; 1518(1-2):1-6. PubMed ID: 11267653 [TBL] [Abstract][Full Text] [Related]
9. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma. Møller MB; Nielsen O; Pedersen NT Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214 [TBL] [Abstract][Full Text] [Related]
10. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p16INK4a/CDK4/pRB and E2F1. Bandyopadhyay D; Medrano EE Ann N Y Acad Sci; 2000 Jun; 908():71-84. PubMed ID: 10911949 [TBL] [Abstract][Full Text] [Related]
11. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein. Nakanishi M; Kaneko Y; Matsushime H; Ikeda K Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249 [TBL] [Abstract][Full Text] [Related]
12. Regulation of BRCA1 expression by the Rb-E2F pathway. Wang A; Schneider-Broussard R; Kumar AP; MacLeod MC; Johnson DG J Biol Chem; 2000 Feb; 275(6):4532-6. PubMed ID: 10660629 [TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the pRb pathway in 2',3'-dideoxycytidine- and 1, 3-butadiene-induced mouse lymphomas. Zhuang SM; Wiseman RW; Söderkvist P Cancer Lett; 2000 May; 152(2):129-34. PubMed ID: 10773403 [TBL] [Abstract][Full Text] [Related]
14. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707 [TBL] [Abstract][Full Text] [Related]
15. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. Alevizopoulos K; Vlach J; Hennecke S; Amati B EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992 [TBL] [Abstract][Full Text] [Related]
16. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes. Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280 [TBL] [Abstract][Full Text] [Related]
17. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases. Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461 [TBL] [Abstract][Full Text] [Related]
18. Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma. Takahashi Y; Oda Y; Kawaguchi K; Tamiya S; Yamamoto H; Suita S; Tsuneyoshi M Mod Pathol; 2004 Jun; 17(6):660-9. PubMed ID: 15098008 [TBL] [Abstract][Full Text] [Related]
19. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Kiess M; Gill RM; Hamel PA Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306 [TBL] [Abstract][Full Text] [Related]
20. Allelic deletions of cell growth regulators during progression of bladder cancer. Primdahl H; von der Maase H; Christensen M; Wolf H; Orntoft TF Cancer Res; 2000 Dec; 60(23):6623-9. PubMed ID: 11118045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]